Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Open Access Highly Accessed Research article

Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial

Vibeke Strand*, Philip Mease, Gerd R Burmester, Enkeleida Nikaï, Geoffroy Coteur, Ronald van Vollenhoven, Bernard Combe, Edward C Keystone and Arthur Kavanaugh

Arthritis Research & Therapy 2009, 11:R170  doi:10.1186/ar2859

Accesses  

  • Last 30 days: 128 accesses
  • Last 365 days: 2827 accesses
  • All time: 9143 accesses